Braselmann, Sylvia et al
"R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation." Journal of Pharmacology and Experimental Therapeutics
319.3
(2006):
998-1008.
Web. 26 Dec. 2024.
